News Japanese pharma set for transformation in 2018 - report Generics and biosimilars to drive growth, according to report.
News Takeda to buy stem cell specialists TiGenix for $626m Decision follows EU regulators' decision to back Crohn's stem cell therapy
News GW files cannabis-based epilepsy drug in EU and US After Sativex disappointment, Epidiolex could transform GW's fortunes.
News Takeda interested in next-generation immuno-oncology deals Japanese firm wants to build presence in cancer
News First ever 'off the shelf' stem cell therapy nears European ... Alofisel recommended for complex perianal fistulas in Crohn's disease
News Takeda depression app impresses in pilot study App corresponds with standard cognitive and patient-reported assessment measures.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.